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Abstract: Pathogens must be able to overcome both
host defenses and antimicrobial treatment in order to
successfully infect and maintain colonization of the host.
One way fungi accomplish this feat and overcome
intercellular toxin accumulation is efflux pumps, in
particular ATP-binding cassette transporters and trans-
porters of the major facilitator superfamily. Members of
these two superfamilies remove many toxic compounds
by coupling transport with ATP hydrolysis or a proton
gradient, respectively. Fungal genomes encode a plethora
of members of these families of transporters compared to
other organisms. In this review we discuss the role these
two fungal superfamilies of transporters play in virulence
and resistance to antifungal agents. These efflux trans-
porters are responsible not only for export of compounds
involved in pathogenesis such as secondary metabolites,
but also export of host-derived antimicrobial compounds.
In addition, we examine the current knowledge of these
transporters in resistance of pathogens to clinically
relevant antifungal agents.
Introduction
Members of the fungal kingdom are found in almost all habitats
and exist as saprobes, commensals, and pathogens. Approximately
11,000 plant diseases have been attributed to fungi in over 120
genera [1], while in the clinical setting, the number of invasive
fungal infections has increased steadily over the past two decades.
Candida sp. is the fourth most common pathogen isolated from
blood cultures [2], and other pathogens such as Cryptococcus sp.,
Aspergillus sp., Fusarium sp., and zygomycetes, have an unacceptably
high morbidity and mortality [3–5]. In addition, the incidence of
mycoses caused by opportunistic fungi is rising [6].
The diverse nature of fungi can be attributed to such factors as
increased capacity to utilize a wide range of carbon and nitrogen
sources, the capability for rapid growth, and the ability to adapt to
otherwise harsh environments. Fungi are constantly bombarded
by toxic compounds from external sources. These compounds can
be synthesized by other microorganisms to impede the fungus for a
competitive advantage to limited resources, synthesized by hosts as
a defense mechanism, or may be present in the environment.
Regardless of the source, these toxic compounds force the fungus
to evolve mechanisms in order to survive. One common method to
overcome these antifungal compounds is active efflux, which
prevents any intracellular build-up of the compound and,
therefore, renders the fungus resistant or tolerant to the otherwise
toxic compound.
As research in mycology progresses it is becoming evident that
transporters are important factors in pathogenicity. Several
transporters have been described as being involved in fungal
pathogenicity, including a range of cellular processes such as
calcium entry, vescicle transport, stress tolerance, dimorphic
switching, capsule synthesis, iron acquition, and virulence factor
enzyme activity [7–16]. This review will focus on the ATP-binding
cassette (ABC) transporters and the major facilitator superfamily
(MFS) transporters associated with secondary metabolites, such as
mycotoxins, and resistance to natural toxic compounds or
antifungal drugs, which have a proven or implicated role in
fungal pathogenesis (Table 1).
Overview of Efflux Pumps
The two most extensively studied families of transporters
involved in efflux are the ABC transporters and the MFS
transporters. Fungi dedicate a large amount of their genome to
encoding transporters, as there are approximately ten to 30 genes
encoding transporters per megabase of genomic DNA in
fungal genomes [17]. The most common type of transporter in
all sequenced fungal genomes to date is the MFS transporter.
However, members of the ABC transporter superfamily are the
most common of the primary transporters (Table 2). Together,
these two superfamilies account for approximately half of all the
genes encoding transporters in fungal genomes. Despite the
importance of these two families of transporters in virulence,
there is no apparent correlation between the quantity of
these transporters in fungal genomes and the pathogenicity of
the fungus (a saprobic isolate versus a pathogenic isolate).
For example, Aspergillus nidulans and the closely related human
pathogen Aspergillus fumigatus both have 45 ABC transporters
encoded in their genomes, and A. nidulans has more MFS
transporters than A. fumigatus (Table 2). Also of note, the
group known as oomycetes, although not members of the
fungal kingdom, but sometimes loosely grouped with fungi,
have 4- to 5-fold more ABC transporters than true fungi; however,
this difference could be due to the larger genome size of the
oomycetes.
Members of the ABC transporter superfamily are primary efflux
transporters, which, as their name implies, hydrolyize ATP for
export of the substrate. This superfamily is further broken into five
families of transporters (ABCA, ABCB, ABCC, ABCD, and
ABCG), of which three families are involved in efflux of toxic
compounds. Members of these three families, ABCB, ABCC, and
ABCG, also referred to as the multi-drug resistance (MDR), multi-
drug resistance–associated protein (MRP), and the pleiotropic
drug resistance (PDR) families, respectively, have been extensively
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possible functions in pathogenic fungi [18,19]. Of the ABC
transporter families, the PDR family has the least amount of
phylogenetic conservation, demonstrating both gene loss and
duplication within yeasts [20] and filamentous fungi, which
suggests that members of this family are rapidly evolving from
outside selective pressures.
The conserved architecture of ABC transporters is composed of
a nucleotide-binding domain (NBD) followed or preceded by six
transmembrane-spanning helices creating a transmembrane
domain (TMD). These two domains together represent the
NBD-TMD6 design of half ABC transporters, which dimerize to
form a fully functional protein [21]. Instead of dimerizing, most
fungal ABC transporters have evolved to be comprised of two
fused NBD-TMD6 half transporters, creating one functional
protein (Figure 1) [21,22].
The MFS transporters are smaller in size compared to the
ABC transporters since they do not require an NBD; however,
they still contain 12 or 14 transmembrane-spanning helices
(Figure 1). Translocation of the substrate is driven by the proton
gradient generated across the plasma membrane [23]. This
family is divided into 17 families, of which two, the drug:H
+
antiporter (14 spanner) (DHA14) and the drug:H
+ antiporter (12-
spanner) (DHA12), are involved in efflux of toxic compounds
[23].
Transporters in Plant Pathogens
Virulence-associated efflux pumps in plant pathogenic fungi can
be classified into two categories. The first class of transporters is
responsible for secretion of virulence factors or compounds
produced by the fungus. Several fungi synthesize and secrete low
molecular weight compounds that are not required for growth.
These compounds, termed secondary metabolites, are bioactive
and are sometimes involved in virulence [24,25]. Secondary
metabolites are commonly synthesized by clusters of genes that
usually include either a polyketide synthase (PKS), nonribsomal
peptide synthase (NRPS), or a fusion of both enzymes (PKS-
NRPS), which is responsible for the majority of the synthesis of the
metabolite [24,25]. Other accessory proteins within the gene
cluster are involved in the secondary metabolite’s biosynthesis, and
frequently one (or more) gene(s) encoding a transporter is
associated with these secondary metabolite gene clusters. Exam-
ples of secondary metabolites are the iron sequestering com-
pounds, termed siderophores [26,27], which are virulence factors
for a number of pathogens [28–30]; mycotoxins such as penicillin
G, gliotoxin, aflatoxin, and lovastatin; and the host-specific and -
nonspecific toxins such as T-toxin, victorin, botrydial, AF-toxin,
and cercosporin [31].
Phytotoxins produced by fungi that are involved in virulence on
a specific host plant, and therefore expand host range, are termed
Table 1. Summary of Transporters Involved in Virulence or Toxin and Drug Efflux.
Transporter
Family Name Fungus Description/Substrate
Amino Acid
Length References
ABC Transporters
PDR/ABCG CDR1 C. albicans Triazole resistance 1500 [60,72]
PDR/ABCG CDR2 C. albicans Triazole resistance 1499 [71–73]
PDR/ABCG CgCDR1 C. glabrata Fluconazole, itraconazole 1542 [59]
PDR/ABCG CgCDR2/PDH1 C. glabrata Fluconazole, ketoconazole 1499 [61,85]
PDR/ABCG CgSNQ2 C. glabrata Fluconazole, itraconazole 1507 [62]
PDR/ABCG AFR1 C. neoformans Triazole resistance 1543 [58]
PDR/ABCG ABC1 M. grisea Unknown function 1619 [46]
PDR/ABCG GpABC1 G. pulicaris Rishitin tolerance 1491 [51]
PDR/ABCG Mgatr4 M. graminicola Unknown function 1635 [49]
PDR/ABCG BcatrB B. cinerea Resveratrol tolerance 1439 [48,50]
MRP/ABCC MLT1 C. albicans Unknown function, possibly bile 1606 [55]
MFS Transporters
DHA14 TOXA C. carbonum HC-toxin secretion 548 [34]
DHA14 TRI12 F. sporotrichioides Trichothecene T-2 secretion 598 [40]
DHA14 CFP C. kikuchii Cercosporin secretion 607 [35]
DHA12 CTB4 C. nicotianae Cercosporin secretion 512 [36]
DHA12 cefT A. chrysogenum Cephalosporin secretion 561 [42]
DHA14 PEP5 N. haematococca Unknown function 592 [52]
DHA12 MDR1 C. albicans Fluconazole resistance 564 [76–78]
DHA12 FLU1 C. albicans Fluconazole resistance 610 [79]
DHA12 CdMDR1 C. dubliniensis Fluconazole resistance 557 [80,81]
DHA12 TMP1 C. albicans MDR 561 [83]
DHA12 TMP2 C. albicans MDR 581 [83]
Transporters involved in virulence are in bold.
doi:10.1371/journal.ppat.1000486.t001
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produce HSTs, they are important virulence factors for members
of the Cochliobolus and Alternaria species [31,32]. For example, the
phytopathogenic fungus Cochliobolus carbonum produces a cyclic
tetrapeptide HST, termed HC-toxin, which functions as an
inhibitor of histone deacetylases in several organisms and is a
virulence factor on maize [33]. The synthesis of this compound is
carried out by an NRPS named HTS1 [33], and the locus
responsible for the synthesis of this compound contains two genes
encoding MFS transporters, termed TOXA and TOXB, postulated
to be responsible for efflux of HC-toxin into the host plant cell
[34]. In another example, the plant pathogenic Cercospora species
produces a host-nonselective toxin, cercosporin, which is also
synthesized by a secondary metabolite gene cluster. Cercosporin is
exported out of the fungal cell by the cercosporin facilitator
protein (CFP) in C. kikuchii and by CTB4 in C. nicotinae [35,36].
These 12-membrane-spanning MFS transporters appear to be
orthologous, and mutants of these genes are reduced in virulence
on their host plants. However, the rice pathogen Magnaporthe grisea
produces a secondary metabolite via the PKS-NRPS fusion
protein termed ACE1 and the surrounding accessory proteins.
This cluster contains a gene encoding an MFS transporter (MFS1),
although it is not involved in efflux of the ACE1 metabolite as it
has a deletion of a single base pair resulting in an early stop codon
[37]. Therefore, the ACE1 metabolite must rely on another
transporter encoded outside the secondary metabolite gene cluster
for export.
Efflux pumps in secondary metabolite gene clusters that are
responsible for synthesis of mycotoxins are less well understood.
The expression of MFS transporters in mycotoxin secondary
metabolite clusters appears not to be controlled by the same
transcription factors as the rest of the secondary metabolite cluster
but, instead, is induced by the accumulation of the synthesized
metabolite [38,39]. However, the ABC transporter TRI12 in the
trichothecene T-2 toxin cluster contains the conserved sequence in
the promoter region for binding of the cluster’s transcription
factor, suggesting it is under the same control as the rest of the
gene cluster [40]. Mutants of efflux pumps in secondary metabolite
clusters have been constructed, and most of these mutants retain
wild-type levels of mycotoxin secretion [38,39,41]. However,
studies where the efflux pump was expressed in a homologous
system or increased in copy number resulted in either efflux of the
compound or a corresponding increase in efflux [40,42],
demonstrating that the transporters are actually involved in efflux
of the mycotoxin. The most obvious reason why mutants of
transporters in secondary metabolite clusters lack a reduction of
toxin secretion is due to other transporters with an overlapping
substrate range. Supporting this notion, mutants of the ABC
transporter atrD in Aspergillus nidulans, although not in a cluster,
produce less penicillin than the wild-type, suggesting this
transporter is involved in efflux of the compound [43].
The second class of transporters involved in plant virulence is
responsible for efflux of molecules produced by the host plant. As a
defense mechanism, plants produce antimicrobial compounds.
These low molecular weight compounds, termed phytoalexins or
phytoanticipins depending on when they are synthesized, have
diverse chemical structures. Over 25 years ago, studies conducted
on Nectria haematococca MPVI and the pea phytoalexin pisatin
suggested that a fungal efflux mechanism is involved in the
tolerance to this plant-derived defense compound and, therefore,
may be a pathogenicity factor [44,45]. However, it was not until
15 years later that the first fungal ABC transporter (ABC1) was
demonstrated to be a virulence factor in the phytopathogenic
fungus M. grisea, the causative agent of rice blast disease [46].
Since that time a number of ABC transporters have been
identified as virulence factors on host plants. Most of these
transporters are members of the PDR family of ABC transporters
(Table 1). A number of phytoalexins and other toxic compounds
induce expression of these fungal transporters [46–50]; however,
only a few have demonstrated the ability to confer tolerance to a
known phytoalexin. The ABC transporters BcatrB in Botrytis cinerea
and GpABC1 in Gibberella pulicaris provide tolerance to the host
plant’s phytoalexins, resveratrol and rishitin, respectively [48,51].
A BcatrB mutant is reduced in pathogenicity on grape leaves [48],
while a GpABC1 mutant is essentially nonpathogenic on potato
[51]. Few examples of fungal MFS transporters involved in
tolerance to phytoalexins exist, although a MFS transporter from
N. haematococca is able to confer an increase in pathogenicity on pea
Table 2. Number of ABC and MFS Transporters in Sequenced
Fungal and Oomycete Genomes.
Classification Fungus ABC
a MFS
Oomycetes Phytophthora infestans 160 102
Phytophthora ramorum 185 113
Phytophthora sojae 190 109
Chytridiomycota Batrachochytrium dendrobatidis 52 23
Zygomycota Rhizopus oryzae 44 111
Basidiomycota Ustilago maydis 38 91
Puccinia graminis 26 35
Cryptococcus neoformans JEC21 29 192
C. neoformans H99 32 159
Coprinus cinereus 47 95
Phanerochaete chrysosporium 56 113
Ascomycota
Taphrinomycotina Schizosaccharomyces pombe 95 8
Saccharomycotina Saccharomyces cerevisiae 24 85
Candida albicans SC5314 21 85
Eurotiomycetes Aspergillus nidulans 45 356
Aspergillus fumigatus 45 275
Penicillium chrysogenum 51 416
Coccidioides posadasii C735 30 146
Paracoccidioides brasiliensis Pb18 28 103
Histoplasma capsulatum 33 86
Microsporum gypseum 45 178
Dothideomycetes Stagonospora nodorum 46 301
Leotiomycetes Sclerotinia sclerotiorum 44 169
Botrytis cinerea 51 204
Sordariomycetes Magnaporthe grisea 50 251
Chaetomium globosum 41 155
Neurospora crassa 31 141
Gibberella zeae (Fusarium grmainearium)56 335
The number of transporters in each genome was calculated from either the
genome publication (P. chrysosporium, P. chrysogenum), the TransporterDB (P.
infestans, P. ramorum, P. sojae, C. neoformans JEC21, S. pombe, S. cerevisiae, A.
nidulans, A. fumigatus, C. posadasii, N. crassa) or from searching the Broad
Fungal Genome Initiative Web site (http://www.broad.mit.edu/node/304) for
the PFAM domains corresponding to the transporter.
aThe number of ABC transporters from genomes from the Broad Fungal
Genome Initiative includes the number of ABCE and ABCF proteins (usually 4–5
members), as they contain the conserved sequence; however, they are not
transporters.
doi:10.1371/journal.ppat.1000486.t002
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transporter–encoding gene, termed PEP5 for pea pathogenicity, is
induced upon exposure to the pea phytoalexin pisatin [53];
however, the mechanism by which PEP5 contributes to virulence
remains unknown.
Fungicide resistance is also due to ABC and MFS transporters.
Several transporters in the agriculturally relevant fungi B. cinerea
and Mycospharella graminicola, as well as the model filamentous
fungus A. nidulans, have been reviewed recently [54]. The ABC
transporter BcatrB of B. cinerea is also able to provide resistance to
the fungicides fenpiclonil and fludioxonil in addition to resveratrol,
as referenced above [48,50].
Transporters Involved in Mammalian Virulence
The most common human pathogenic fungus, C. albicans, has a
total of 21 ABC transporters and 85 MFS transporters encoded
within its genome (Table 2). A single ABC transporter that is
required for full virulence has been identified in C. albicans. This
transporter, MLT1, is a vacuolar transporter and a member of the
ABCC/MRP family of proteins. Mutants of this transporter are
severely defective in invasion of the liver and pancreas in a mouse
peritonitis virulence assay and cause less hepatic tissue damage
[55]. The exact substrate(s) of this efflux pump are not currently
known; however, MLT1 is similar to the bile pigment transporter
BPT1 in S. cerevisiae, which is involved in sequestering unconju-
gated bilirubin and glutathione conjugates in the vacuole [56,57],
suggesting that MLT1 is involved in resistance to similar
compounds.
ABC Transporters in Clinical Multi-Drug
Resistance
Although not directly involved in virulence, the ability to
provide resistance to antifungal compounds does provide a
‘‘colonization’’ advantage to the fungus and, therefore, merits
further discussion.
A number of transporters that confer resistance to members of
the antifungal class of triazoles have been described. These include
the ABC transporters CDR1 and CDR2 in C. albicans; AFR1 in C.
neoformans; ABC1 in C. krusei; and CgCDR1, PDH1 (also referred
to as CgCDR2), and SNQ2 in C. glabrata [58–63]. These
transporters are usually able to provide cross-resistance to the
antifungal class of triazoles (fluconazole, itraconazole, ketocona-
zole, voriconazole); however, studies suggest they are not
responsible for echinocandin resistance or resistance to the
antifungal protein histatin 5 [64,65]. These transporters are
closely related and all belong to the PDR family, which includes
the well-characterized PDR5 transporter in S. cerevisiae. The PDR
family is one of the largest families of ABC transporters in fungi
and is overrepresented when their numbers are compared to other
organisms, i.e., there are five and nine ABCG/PDR transporters
in humans and Caenorhabditis elegans, respectively [66,67]. Although
initially identified for conferring an MDR phenotype, studies of
CDR1 and CDR2, and most likely the orthologous genes in other
pathogenic fungi, have demonstrated that their physiological
function is the transport of phospholipids and steroids across the
membrane [68–70].
Of the transporters involved in fluconazole resistance in
medically important fungi, CDR1 and CDR2 are the most
studied. Despite their high degree of amino acid similarity, there
are functional differences between the two. Mutants of CDR2
retain a wild-type level of resistance to fluconazole; however, in a
double mutant (DCDR1/DCDR2) the strain is more susceptible to
fluconazole than either single mutant [71]. Other differences in
function have been identified, suggesting that the two ABC
transporters have separate, but overlapping, roles in the fungus
[72]. In addition, there is allelic variation of the genes.
Comparison of the CDR2 alleles uncovered two point mutations
in equal frequency of an allele in transmembrane helix 12 that
were involved in substrate binding and function [73]. Most strains
were heterozygous for these CDR2 genes, and further phylogenetic
analysis suggested that as many as 33 codon changes between the
two alleles may be selectively advantageous [73]. Differences in
transmembrane domains are significant, as evidence builds that
they are responsible for substrate specificity. Most ABC trans-
porters have been demonstrated to have multiple substrates; thus,
it is postulated that substrate binding does not occur in a specific
active site, but rather in an active pocket able to accommodate a
variety of structurally different compounds [74,75]. Several amino
acids are conserved among these transmembrane helices of
fluconazole PDR transporters, where the most conserved helices
are 6 and 12.
MFS Transporters in Clinical Multi-Drug
Resistance
In addition to ABC transporters, a number of MFS transporters
also are responsible for increased resistance to fluconazole. The
two best characterized are MDR1 (formally BEN
r) and FLU1 in C.
Figure 1. Schematic representation of the two main fungal transporters responsible for efflux of toxic compounds. Representation of
an ABC transporter of the PDR family (A) and an MFS transporter of the DHA12 family (B). The NBDs of the ABC transporter are depicted in red, while
the TMDs important for substrate specificity are colored green and gold for the ABC and MFS transporters, respectively.
doi:10.1371/journal.ppat.1000486.g001
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fluconazole resistance in C. dubliniensis [80,81] and C. tropicalis [82].
Unlike the ABC transporters, the resistance conferred by MFS
transporters is more specific for fluconazole than other triazoles,
although other substrates have been identified [76,80]. Of
particular importance for MDR1 function is transmembrane
domain 5, which harbors a conserved motif important for drug:H
+
translocation (Figure 1) [78]. Other MFS transporters (TMP1 and
TMP2) confer increased resistance to a number of unrelated
antifungal drugs in C. albicans [83]. It should be noted that
other transporters may be involved in resistance to antifungals.
For example, the Sec14p family member PDR16 transporter in
C. albicans is upregulated in fluconazole-resistant clinical isolates,
and confers a 2-fold increased resistance to the azole antifungal
[84].
Expression of Efflux Pumps in the Multi-Drug
Resistance Phenomenon
Pathogenic isolates are able to develop resistance to prescribed
antifungal treatment rapidly [85,86]. While other factors contrib-
ute to this increase in resistance, one reason is the increase in
transcription of drug transporters [85,87–91]. A shared 22–base
pair sequence in the promoters of CaCDR1 and CaCDR2, termed
the drug responsive element, serves as the binding site of the Zn(2)-
Cys(6) finger transcription factor TAC1 [92,93]. Although azole-
resistant isolates have been demonstrated to sometimes carry an
extra copy of the chromosome that has CDR1 and CDR2, the
transcript levels did not increase [94], confirming other studies
that suggest the increase in transcription is due to either the
promoter or trans-acting factors of the CDR genes [95]. Indeed, a
second chromosomal rearrangement was identified where resistant
isolates frequently harbor duplications of the chromosomal region
in which TAC1 resides [96]. Recently, the analogous transcription
factors of TAC1 in C. glabrata (CgPDR1 and CgPDR3) have been
demonstrated to bind the substrate, promoting the expression of
the efflux pumps under its control [97]. Another zinc finger
transcription factor (MRR1) is responsible for the overexpression
of the MFS transporter encoding gene MDR1 [98]. Two point
mutations in MRR1 of azole-resistant isolates were identified as
rendering the transcription factor constitutively active [98,99].
Unlike MDR1, expression of FLU1 in clinically resistant isolates is
not increased, and therefore FLU1 is not believed to contribute
significantly to resistance to fluconazole [79].
A major difference in the mutations of the major transcription
factors that confer fluconazole resistance is the heritability of the
resistance phenotype. The CDR1/CDR2 overexpressing C. albicans
isolates require the TAC1 fluconazole-resistant transcription factor
to be homozygous, as heterogygous isolates retain wild-type levels
of fluconazole susceptibility [100]; however, the nature of the point
mutations of MRR1, which render the transcription factor
constitutively active, functions in a semi-dominant manner, as a
single copy of the fluconazole-resistant mutant MRR1 increases
fluconazole resistance [98]. Other transcription factors involved in
CDR1, CDR2, and MRR1 overexpression have been identified, but
their role in clinical resistance is less understood. These
transcription factors include CaNdt80 in CDR1 overexpression
[101], and Cup1 and Mcm1 in MDR1 overexpression [102,103].
Recent studies also describe an increase in mRNA stability of
CDR1 transcripts in fluconazole-resistant C. albicans isolates that
results in an increase in the number of CDR1 transporters [104].
Conclusions
The role of efflux pumps, in particular ABC and MFS
transporters, in fungal virulence cannot be understated. These
transporters contribute to pathogenesis by 1) transporting HSTs
and mycotoxins outside of the cell, 2) removing host-derived
compounds that would otherwise inhibit the fungus, and 3)
providing resistance to clinical antifungals. This concept is further
supported by the vast amount of substrate redundancy already
evidenced with the few transporters that have been extensively
studied. Considering S. cerevisiae and C. albicans have relatively few
ABC and MFS transporters compared to filamentous fungi, and
the scope of research already conducted on these important yeast
superfamilies, it appears there is much more to be discovered in
other fungi.
The redundant nature of the transporters creates difficulty in
characterization of the efflux mechanisms, as single deletion
mutants sometimes retain a wild-type phenotype, and it is only
through multiple mutations of transporters or expression in
heterologous systems that the function of the transporters becomes
apparent. Although a daunting endeavor, understanding all of the
contributing efflux factors of a given antimicrobial will provide a
means to circumvent efflux transporters.
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